Enovis Corp Business Combination, Integration Related Costs
Enovis Corp (ENOV) reported Business Combination, Integration Related Costs of $1.41 million for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationIntegrationRelatedCosts · last filed 2026-08-06
- Enovis Corp business combination, integration related costs for the quarter ending 2026-07-03 was $1.41M, a 89.53% decline year-over-year.
- Enovis Corp business combination, integration related costs for the quarter ending 2026-04-03 was $11.03M, a 8.48% decline year-over-year.
- Enovis Corp business combination, integration related costs for the quarter ending 2025-12-31 was $19.19M, a 43.94% increase year-over-year.
- Enovis Corp business combination, integration related costs for the quarter ending 2025-10-03 was $15.68M, a 26.85% decline year-over-year.
- Enovis Corp business combination, integration related costs for fiscal 2025 was $60.37M, a 22.89% decline from fiscal 2024.
- Enovis Corp business combination, integration related costs for fiscal 2024 was $78.29M, a 104.68% increase from fiscal 2023.
- Enovis Corp business combination, integration related costs for fiscal 2023 was $38.25M, a 37.32% decline from fiscal 2022.
- Enovis Corp business combination, integration related costs for fiscal 2022 was $61.02M, a 160.25% increase from fiscal 2021.
| Period end | Business Combination, Integration Related Costs 3 month | Business Combination, Integration Related Costs 6 month | Business Combination, Integration Related Costs 9 month | Business Combination, Integration Related Costs 12 month |
|---|---|---|---|---|
| 2026-07-03 | $1.41M 10-Q · filed 2026-08-06 | $12.44M 10-Q · filed 2026-08-06 | $31.63M derived: sum of 3 quarters · filed 2026-08-06 | $47.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-04-03 | $11.03M 10-Q · filed 2026-05-07 | $30.22M derived: sum of 2 quarters · filed 2026-05-07 | $45.90M derived: sum of 3 quarters · filed 2026-05-07 | $59.35M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $19.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $34.87M derived: sum of 2 quarters · filed 2026-02-26 | $48.32M derived: sum of 3 quarters · filed 2026-08-06 | $60.37M 10-K · filed 2026-02-26 |
| 2025-10-03 | $15.68M 10-Q · filed 2025-11-06 | $29.13M derived: sum of 2 quarters · filed 2026-08-06 | $41.18M 10-Q · filed 2025-11-06 | $54.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-07-04 | $13.45M 10-Q · filed 2026-08-06 | $25.50M 10-Q · filed 2026-08-06 | $38.84M derived: sum of 3 quarters · filed 2026-08-06 | $60.27M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-04-04 | $12.05M 10-Q · filed 2026-05-07 | $25.39M derived: sum of 2 quarters · filed 2026-05-07 | $46.81M derived: sum of 3 quarters · filed 2026-05-07 | $69.51M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $13.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $34.76M derived: sum of 2 quarters · filed 2026-02-26 | $57.45M derived: sum of 3 quarters · filed 2026-02-26 | $78.29M 10-K · filed 2026-02-26 |
| 2024-09-27 | $21.43M 10-Q · filed 2025-11-06 | $44.12M derived: sum of 2 quarters · filed 2025-11-06 | $64.96M 10-Q · filed 2025-11-06 | $75.66M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-28 | $22.69M 10-Q · filed 2025-08-07 | $43.53M 10-Q · filed 2025-08-07 | $54.23M derived: sum of 3 quarters · filed 2026-02-26 | $64.72M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-29 | $20.84M 10-Q · filed 2025-05-08 | $31.54M derived: sum of 2 quarters · filed 2026-02-26 | $42.02M derived: sum of 3 quarters · filed 2026-02-26 | $47.46M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $10.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $21.18M derived: sum of 2 quarters · filed 2026-02-26 | $26.62M derived: sum of 3 quarters · filed 2026-02-26 | $38.25M 10-K · filed 2026-02-26 |
| 2023-09-29 | $10.48M 10-Q · filed 2024-11-06 | $15.92M derived: sum of 2 quarters · filed 2024-11-06 | $27.55M 10-Q · filed 2024-11-06 | $56.02M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $5.43M 10-Q · filed 2024-08-07 | $17.07M 10-Q · filed 2024-08-07 | $45.54M derived: sum of 3 quarters · filed 2025-02-26 | $53.69M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $11.63M 10-Q · filed 2024-05-02 | $40.10M derived: sum of 2 quarters · filed 2025-02-26 | $48.25M derived: sum of 3 quarters · filed 2025-02-26 | $60.96M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $28.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $36.62M derived: sum of 2 quarters · filed 2025-02-26 | $49.33M derived: sum of 3 quarters · filed 2025-02-26 | $61.02M 10-K · filed 2025-02-26 |
| 2022-09-30 | $8.15M 10-Q · filed 2023-11-07 | $20.85M derived: sum of 2 quarters · filed 2023-11-07 | $32.55M 10-Q · filed 2023-11-07 | $40.22M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-07-01 | $12.71M 10-Q · filed 2023-08-03 | $24.40M 10-Q · filed 2023-08-03 | $32.07M derived: sum of 3 quarters · filed 2024-02-22 | $43.43M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-04-01 | $11.70M 10-Q · filed 2023-05-04 | $19.36M derived: sum of 2 quarters · filed 2024-02-22 | $30.73M derived: sum of 3 quarters · filed 2024-02-22 | $34.76M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $7.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $19.03M derived: sum of 2 quarters · filed 2024-02-22 | $23.07M derived: sum of 3 quarters · filed 2024-02-22 | $23.45M 10-K · filed 2024-02-22 |
| 2021-10-01 | $11.36M 10-Q · filed 2022-11-02 | $15.40M derived: sum of 2 quarters · filed 2022-11-02 | $15.78M 10-Q · filed 2022-11-02 | |
| 2021-07-02 | $4.04M 10-Q · filed 2022-08-04 | $4.42M 10-Q · filed 2022-08-04 | ||
| 2020-12-31 | $2.80M 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |